Diapin News & Announcements
September 17, 2024
Dr. Shamir Mehta Joins Diapin Therapeutics Scientific Advisory Board Read Bio+
August 14, 2024
Patent Application No. 2021-531620 (Granted), Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders (Japan)
March 27, 2024
Patent No. 201980012798.2 (Issued), Biocatalyst and Methods for Synthesizing Mixed Disulfide Conjugates of Thienopyridine Compounds (China)
August 1, 2023
Dr. Arun J. Sanyal Joins Diapin Therapeutics Scientific Advisory Board Read Bio+
May 04, 2023
May 15, 2022
Irvine H.Page Junior Faculty Research Awarded to Oren Rom, PhD
April 13, 2022
August 26, 2021
March 25, 2021
December 03, 2020
Amino Acid Connected to NAFLD Could Provide Treatment Clues
December 09, 2020
March 22, 2019
April 11, 2018
March 15, 2018
August 01, 2017
August 01, 2017
August, 30, 2016
June 1, 2016
Patent CN105617351A (Issued), Peptide compositions and methods for treating patients (China)
December 01, 2015
August 28, 2015
March 02, 2015
Diapin Therapeutics Announces Allowance of Claims from US Patent Application 14/087,247
February 01, 2015
November 18, 2014
March 25, 2014
March 14, 2013
September 15, 2011
December 30, 2011
Beijing Shuanglu Pharmaceutical to Invest in Diapin Therapeutics in Research in China